Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coates

Showing results (401-410 of 575) with videos related to

Pageof 58
Sort By:
The Lancet. Rheumatology|January 30, 2024
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 studyLaura C Coates, William Tillett, Maria-Antonietta D'Agostino, et al.
Advances in Nutrition (Bethesda, Md.)|March 27, 2026
Healthy diet metrics for children and adolescents and their suitability for global monitoring: a critical reviewAlissa M Pries, Hope Craig, Vrinda Mehra, et al.
The Journal of Rheumatology|July 5, 2011
Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest groupLaura C Coates, Aizad Mumtaz, Philip S Helliwell, et al.
The Journal of Rheumatology|November 3, 2014
Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic reviewMaria Laura Acosta Felquer, Laura C Coates, Enrique R Soriano, et al.
International Journal of Women'S Dermatology|January 14, 2022
Impact of psoriatic disease on women aged 18 to 45: Results from a multinational survey across 11 European countriesSandy R McBride, Maria C Fargnoli, Anne-Claire Fougerousse, et al.
Joint Bone Spine|March 8, 2022
Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysisFlorian Lucasson, Andra Balanescu, Uta Kiltz, et al.
RMD Open|January 31, 2024
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritisLaure Gossec, Ana-Maria Orbai, Laura C Coates, et al.
Seminars in Arthritis and Rheumatism|June 11, 2020
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 studyLaura C Coates, Peter Nash, Tore K Kvien, et al.
Rheumatology and Therapy|November 11, 2018
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 StudiesPeter Nash, Laura C Coates, Roy Fleischmann, et al.
Rheumatology (Oxford, England)|January 30, 2026
Comment on: Key factors contributing to gender inequity in global rheumatology awards: a global survey analysis: ReplyLekshmi Minikumari Rahulan, Laura C Coates, Laura Andreoli, et al.
Pageof 58

Showing results (401-410 of 575) with videos related to

Sort By:
Pageof 58
The Lancet. Rheumatology|January 30, 2024
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 studyLaura C Coates, William Tillett, Maria-Antonietta D'Agostino, et al.
Advances in Nutrition (Bethesda, Md.)|March 27, 2026
Healthy diet metrics for children and adolescents and their suitability for global monitoring: a critical reviewAlissa M Pries, Hope Craig, Vrinda Mehra, et al.
The Journal of Rheumatology|July 5, 2011
Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest groupLaura C Coates, Aizad Mumtaz, Philip S Helliwell, et al.
The Journal of Rheumatology|November 3, 2014
Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic reviewMaria Laura Acosta Felquer, Laura C Coates, Enrique R Soriano, et al.
International Journal of Women'S Dermatology|January 14, 2022
Impact of psoriatic disease on women aged 18 to 45: Results from a multinational survey across 11 European countriesSandy R McBride, Maria C Fargnoli, Anne-Claire Fougerousse, et al.
Joint Bone Spine|March 8, 2022
Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysisFlorian Lucasson, Andra Balanescu, Uta Kiltz, et al.
RMD Open|January 31, 2024
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritisLaure Gossec, Ana-Maria Orbai, Laura C Coates, et al.
Seminars in Arthritis and Rheumatism|June 11, 2020
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 studyLaura C Coates, Peter Nash, Tore K Kvien, et al.
Rheumatology and Therapy|November 11, 2018
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 StudiesPeter Nash, Laura C Coates, Roy Fleischmann, et al.
Rheumatology (Oxford, England)|January 30, 2026
Comment on: Key factors contributing to gender inequity in global rheumatology awards: a global survey analysis: ReplyLekshmi Minikumari Rahulan, Laura C Coates, Laura Andreoli, et al.
Pageof 58